The Effectiveness and Limitations of Mental Health Apps

Introduction

Purpose of the article

The purpose of this article is to provide a comprehensive and critical review of the effectiveness and limitations of mental health apps, with particular attention to their empirical evidence base, real-world performance, and role within contemporary mental health care systems. Over the past decade, mobile applications targeting mental well-being, stress reduction, anxiety, depression, and related conditions have proliferated at an unprecedented pace. Thousands of mental health–related apps are now available across major app stores, marketed to consumers, clinicians, employers, and health systems alike. Despite this rapid expansion, uncertainty remains regarding what these tools can realistically achieve and for whom they are most appropriate.

This review aims to move beyond promotional narratives and binary judgments of success or failure. Instead, it evaluates mental health apps as a heterogeneous class of interventions, ranging from simple mood trackers and mindfulness exercises to more structured, therapy-informed programs and clinician-facing digital tools. The article examines how effectiveness is defined and measured in the literature, how outcomes vary across conditions and populations, and how methodological and contextual factors influence reported results.

Importantly, this review does not treat mental health apps as substitutes for professional care. Rather, it situates them within broader models of prevention, early intervention, self-management, and adjunctive support. By synthesizing findings from randomized controlled trials, meta-analyses, implementation studies, and policy reviews, the article seeks to clarify the appropriate role of mental health apps, identify their limitations, and outline evidence-informed pathways for their responsible use in clinical and public health contexts.

Brief overview of key issues

Mental health apps have emerged in response to long-standing challenges in mental health care delivery, including limited access to services, workforce shortages, long wait times, high costs, and stigma associated with seeking help. Smartphones offer a scalable platform capable of delivering interventions at low marginal cost, often without geographic constraints. These features have fueled optimism that apps could democratize mental health support, particularly for individuals who might otherwise receive no care at all. At the same time, the rapid commercialization of mental health apps has outpaced the development of regulatory oversight and scientific validation. While some apps are grounded in established therapeutic principles such as cognitive behavioral therapy or mindfulness-based stress reduction, many others provide minimal transparency regarding their theoretical basis, data use practices, or evidence of benefit. App store descriptions often emphasize symptom relief and emotional well-being without clearly distinguishing between wellness support and clinical intervention, creating ambiguity for users and clinicians alike.

A central issue addressed in this article is the gap between efficacy and effectiveness. Controlled trials frequently report small to moderate reductions in self-reported symptoms for certain app-based interventions, particularly for depression and anxiety. However, real-world usage data reveal high rates of disengagement, brief periods of use, and limited adherence to recommended intervention protocols. This discrepancy raises questions about the generalizability of trial results and the durability of observed benefits outside research settings.

Another key concern involves measurement and outcome selection. Many studies rely on short-term symptom scales, with limited attention to functional outcomes, quality of life, or long-term recovery. Adverse effects, including increased distress, false reassurance, or delayed help-seeking, are rarely assessed systematically. These gaps complicate efforts to weigh benefits against potential harms.

Ethical, social, and equity-related issues further shape the debate. Mental health apps routinely collect sensitive personal data, often with opaque privacy practices. Digital divides related to age, socioeconomic status, disability, and language may limit access or effectiveness for certain populations. Moreover, the growing reliance on app-based solutions raises broader questions about whether digital tools are being used to complement mental health services or to compensate for underinvestment in human care. Against this complex backdrop, this article examines what is currently known and not known about mental health apps. The sections that follow trace their historical development, review current research trends, assess practical applications and limitations, and explore ongoing controversies surrounding their use. By adopting a balanced, evidence-based perspective, the article aims to contribute to more informed decision-making by clinicians, researchers, policymakers, and users navigating the expanding digital mental health landscape.

Historical Context

Historical background

The development of mental health apps can be traced to earlier efforts to deliver psychological interventions through digital and computerized platforms, long before the widespread adoption of smartphones. In the 1990s and early 2000s, the first generation of computer-assisted mental health interventions emerged in the form of desktop-based programs and web-delivered self-help modules. Many of these early tools were grounded in cognitive behavioral therapy (CBT) principles and were designed to replicate structured therapeutic exercises such as cognitive restructuring, behavioral activation, and exposure in a standardized, self-guided format. As internet access expanded, web-based mental health interventions gained visibility as a potential solution to access barriers. Early randomized trials demonstrated that internet-delivered CBT could reduce symptoms of depression and anxiety, particularly when accompanied by minimal clinician support. These findings established the conceptual foundation for later mobile interventions, highlighting both the promise of scalability and the persistent challenge of sustaining user engagement outside traditional therapeutic relationships.

The transition from web-based programs to mobile apps accelerated with the widespread adoption of smartphones in the late 2000s and early 2010s. Smartphones introduced new capabilities, including constant availability, push notifications, sensor data collection, and real-time interaction. These features were widely interpreted as opportunities to deliver mental health support that was more personalized, responsive, and embedded in daily life. Early mental health apps focused on simple functions such as mood tracking, journaling, and guided relaxation, often drawing on principles from mindfulness-based stress reduction and positive psychology.

However, this rapid shift also marked a departure from the slower, research-driven development cycles that characterized earlier digital interventions. App development became increasingly driven by commercial incentives, with relatively low barriers to market entry. As a result, the number of mental health apps grew exponentially, while the proportion supported by empirical evidence remained small. This divergence between availability and validation continues to shape contemporary debates about effectiveness and safety.

Research developments

Research on mental health apps initially mirrored earlier work on internet-based interventions, focusing on symptom reduction and feasibility. Early studies often involved small samples, short follow-up periods, and high levels of researcher involvement, limiting generalizability. Nonetheless, these trials provided preliminary evidence that app-based CBT and mindfulness interventions could produce modest improvements in self-reported depression, anxiety, and stress symptoms.

As the field matured, research priorities expanded to address engagement, adherence, and real-world use. Investigators began to recognize that effectiveness depended not only on therapeutic content but also on design, usability, and user motivation. High attrition rates emerged as a consistent finding across studies, prompting greater emphasis on human-centered design and behavioral engagement strategies. This shift reflected a broader understanding that digital mental health tools function within complex behavioral and social contexts, rather than as isolated interventions. More recently, research has turned toward implementation science and comparative effectiveness. Meta-analyses have attempted to synthesize outcomes across heterogeneous app types, revealing small to moderate average effect sizes with substantial variability. At the same time, concerns about methodological quality, selective reporting, and lack of replication have grown more prominent. Regulatory and policy-oriented research has also increased, examining how mental health apps fit within medical device frameworks, data protection laws, and clinical governance structures.

Taken together, the historical evolution of mental health apps reflects a tension between technological innovation and scientific rigor. While digital platforms have enabled unprecedented reach, research has struggled to keep pace with commercial development. Understanding this trajectory is essential for interpreting current evidence and for setting realistic expectations about what mental health apps can and cannot achieve in practice.

Current Trends and Research

Review of relevant research and evidence

The contemporary evidence base on mental health apps is extensive but highly heterogeneous, reflecting wide variation in app design, therapeutic approach, target population, and study quality. Most empirical research has focused on apps targeting depression, anxiety, stress, and general emotional well-being, with far fewer studies addressing severe mental illness, suicidality, or complex comorbid conditions. As a result, conclusions about effectiveness must be carefully contextualized.

Randomized controlled trials (RCTs) remain the primary method used to evaluate app efficacy, although their design and rigor vary considerably. Meta-analyses of RCTs examining app-based interventions for depression and anxiety generally report small to moderate reductions in symptom severity compared with inactive controls such as waitlists or psychoeducation-only apps. Effect sizes are typically smaller when compared with active controls or clinician-supported interventions. These findings suggest that mental health apps can produce measurable benefits under certain conditions, but they rarely approach the effectiveness of face-to-face psychotherapy.

A recurring feature of the literature is the dominance of self-guided interventions, most commonly based on cognitive behavioral therapy, mindfulness, or behavioral activation principles. Apps incorporating structured CBT elements—such as mood monitoring, cognitive reframing exercises, and goal setting—tend to perform better than apps offering unstructured content or generic motivational messages. Mindfulness and meditation apps show consistent effects on stress and well-being, though their impact on clinical depression and anxiety is more variable and often modest.

Importantly, many trials enroll participants with mild to moderate symptoms, often recruited from non-clinical populations through online advertising or university settings. This limits the generalizability of findings to individuals with more severe or chronic mental health conditions. Studies involving clinically diagnosed patients are less common and often show weaker effects, underscoring the challenge of translating app-based interventions into higher-acuity care contexts. Beyond symptom reduction, fewer studies examine functional outcomes, such as quality of life, social functioning, or work productivity. Where these outcomes are measured, improvements are generally smaller and less consistent than changes in symptom scores. Long-term follow-up data are particularly scarce; most studies assess outcomes over periods of 4 to 12 weeks, leaving questions about durability of benefit largely unanswered.

Observational and real-world studies provide additional insight but introduce new complexities. Usage data consistently demonstrate rapid attrition, with a majority of users discontinuing app use within days or weeks. Even among participants who initially engage, adherence to recommended intervention “doses” is low. These patterns suggest that trial conditions, which often include reminders, incentives, or researcher contact, may substantially overestimate real-world effectiveness, where motivation, support, and accountability are lower. Another emerging area of research involves comparative effectiveness and personalization. Some studies suggest that apps incorporating minimal human support, such as periodic coaching messages or clinician check-ins, achieve better outcomes than fully automated tools. Others explore adaptive interventions that tailor content based on user responses or behavior. While promising, this line of research remains early-stage and methodologically complex.

Overall, current evidence supports a qualified conclusion: mental health apps can reduce symptoms for some users, particularly those with mild distress and high motivation, but their effects are typically modest, variable, and fragile. The next sections examine how these findings translate into clinical practice and what conclusions can be drawn about their broader impact.

Role and impact on practice

Mental health apps are increasingly influencing clinical practice, not as replacements for professional care, but as adjunctive, supplementary, or entry-level tools within broader mental health care ecosystems. Their impact is most visible in prevention, early intervention, and self-management, where clinical demand often exceeds available resources. In these contexts, apps are commonly used to provide psychoeducation, symptom monitoring, and basic coping strategies, offering support to individuals who may be waiting for care or are reluctant to engage with formal services.

In clinical settings, mental health apps are most often integrated into stepped-care and collaborative-care models. Clinicians may recommend apps to patients with mild symptoms as a first step, reserving more intensive interventions for those who do not improve. Apps are also used to support ongoing treatment by reinforcing skills learned in therapy, facilitating between-session practice, or tracking symptoms over time. For example, mood tracking and behavioral activation apps can help patients and clinicians identify patterns, triggers, and progress, providing structured data that may inform treatment decisions. Despite these potential benefits, integration into routine practice remains uneven. Many clinicians report uncertainty about which apps to recommend, citing the overwhelming number of options, lack of standardized quality indicators, and limited time to evaluate evidence. As a result, app use is often driven by patient initiative rather than clinician guidance. This dynamic can undermine continuity of care, particularly when apps deliver content that conflicts with therapeutic goals or encourages self-management in situations where professional intervention is warranted.

Mental health apps have also influenced practice by reshaping patient expectations. Patients increasingly arrive at clinical encounters having already engaged with digital tools, bringing data, insights, or assumptions shaped by app experiences. For some clinicians, this enhances collaboration and self-reflection; for others, it introduces challenges when app-derived interpretations oversimplify complex psychological processes. Managing these expectations has become an implicit part of contemporary mental health practice.

From a systems perspective, apps are often positioned as tools to extend reach and efficiency, particularly in under-resourced settings. Health systems, employers, and insurers increasingly deploy app-based programs as population-level interventions aimed at stress reduction or emotional well-being. While such programs may improve access to low-intensity support, evidence suggests that their impact depends heavily on implementation quality, user engagement strategies, and alignment with existing services. Apps deployed in isolation, without referral pathways or human oversight, are less likely to produce meaningful or sustained benefits.

The impact on clinicians themselves is mixed. Some report that app-supported monitoring and structured self-report data can streamline assessment and follow-up, particularly in large caseloads. Others note that reviewing app-generated data adds to workload without clear clinical payoff. These divergent experiences highlight that the burden-shifting potential of apps is context-dependent and influenced by workflow integration, interoperability, and reimbursement structures.

Mental health apps have limited impact in high-acuity or complex clinical contexts. Evidence does not support their use as primary interventions for severe depression, active suicidality, psychotic disorders, or complex trauma. In such cases, reliance on apps may delay appropriate care. Clinical guidelines increasingly emphasize clear boundaries, positioning apps as supportive tools rather than substitutes for professional assessment and treatment.

Overall, the role of mental health apps in practice is best characterized as supportive and conditional. They can enhance access, engagement, and continuity for some users, particularly when embedded within clinician-guided care models. However, their impact is constrained by modest effect sizes, engagement challenges, and variability in quality. Effective use in practice depends less on the mere availability of apps and more on thoughtful integration, clinician oversight, and realistic expectations about what digital tools can deliver.

Key findings and conclusions of current research

The accumulated research on mental health apps yields a set of consistent but nuanced conclusions regarding their effectiveness, scope, and limitations. Across multiple meta-analyses and systematic reviews, the most robust finding is that mental health apps can produce small to moderate reductions in self-reported symptoms, particularly for depression, anxiety, stress, and general psychological distress. These effects are most consistently observed in apps grounded in established therapeutic frameworks, such as cognitive behavioral therapy, mindfulness-based interventions, and behavioral activation. However, the magnitude of benefit is typically modest and highly variable. Effect sizes tend to decrease when app-based interventions are compared with active controls or face-to-face psychotherapy, suggesting that apps are best understood as lower-intensity interventions rather than equivalents to clinician-delivered treatment. Importantly, many positive findings are derived from short-term trials, often lasting no more than 8–12 weeks. Evidence regarding long-term maintenance of symptom improvement is limited, and relapse or symptom recurrence after discontinuation is rarely assessed systematically.

Another key finding concerns population specificity. Most studies enroll participants with mild to moderate symptoms, frequently recruited from community or non-clinical samples. In these groups, apps may function as accessible self-help tools or early interventions. In contrast, evidence supporting effectiveness for individuals with severe mental illness, chronic conditions, or high suicide risk is sparse and inconsistent. This gap highlights the limited applicability of current findings to high-acuity clinical populations.

Engagement and adherence emerge as central determinants of effectiveness. Across studies, higher engagement, measured by frequency of use, completion of modules, or sustained interaction, is associated with better outcomes. Yet real-world usage data consistently show steep attrition curves, with many users discontinuing within days or weeks. This discrepancy suggests that efficacy observed under research conditions often overestimates real-world effectiveness, where motivation, support, and accountability are lower.

Research also indicates that human support matters. Apps that incorporate some degree of clinician involvement, coaching, or guided feedback generally outperform fully automated interventions. Even minimal human contact appears to improve adherence and outcomes, reinforcing the conclusion that apps function best as part of blended or hybrid care models rather than standalone solutions. Methodological limitations recur across the literature. These include reliance on self-reported outcomes, short follow-up periods, selective reporting of positive results, and heterogeneity in app features that complicates synthesis. Adverse effects and unintended consequences, such as increased distress, false reassurance, or delayed help-seeking, are rarely measured, limiting risk–benefit assessment.

Taken together, current research supports a qualified conclusion: mental health apps can be beneficial for some users, under specific conditions, and for specific goals, particularly symptom reduction and self-management in low-risk contexts. They are not substitutes for professional care, nor are they universally effective. Their value depends on evidence-based design, appropriate targeting, sustained engagement, and integration into broader care pathways.

Practical Significance and Potential Applications

Impact on clinical practice

Mental health apps have had a measurable impact on clinical practice primarily by expanding the range of low-intensity supports available to patients and clinicians. Their most common use is in prevention, early intervention, and self-management, particularly for individuals experiencing mild to moderate symptoms who may not yet meet criteria for formal treatment or who face long wait times for care. In these contexts, apps can provide psychoeducation, symptom tracking, and basic coping strategies that may help users recognize difficulties earlier and seek appropriate support.

Within clinical services, apps are increasingly incorporated into stepped-care models, where intervention intensity is matched to symptom severity and response. Clinicians may recommend an app as a first-line option for mild distress, escalating to clinician-led therapy if symptoms persist or worsen. Apps are also used adjunctively to reinforce therapy, supporting between-session practice of skills such as cognitive restructuring, mindfulness, or behavioral activation. When aligned with treatment goals, these tools can enhance continuity and promote patient engagement outside the therapy room. However, real-world implementation reveals significant constraints. Many clinicians report limited confidence in app selection due to the absence of standardized quality benchmarks and the rapid turnover of commercial products. Interoperability with electronic health records is rare, and reviewing app-generated data can add to clinical workload without clear reimbursement or clinical benefit. As a result, app use is often informal and inconsistent, limiting its impact.

Mental health apps have minimal utility in high-acuity contexts. Evidence does not support their use as primary interventions for severe depression, active suicidality, psychosis, or complex trauma. In such cases, reliance on apps may delay necessary care. Clinical guidelines increasingly emphasize clear boundaries, positioning apps as supportive tools rather than substitutes for professional assessment and treatment.

Recommendations and prospects

Current evidence supports several practical recommendations for the responsible use of mental health apps. First, matching app type to clinical need and severity is essential. Apps are most appropriate for self-monitoring, psychoeducation, and skills practice in low-risk populations. Clinician involvement becomes increasingly important as symptom severity, comorbidity, or risk increases.

Second, clinicians should play an active role in curating and contextualizing app use. Rather than simply recommending an app, clinicians can help patients set expectations, integrate app activities into treatment plans, and periodically review progress. This guided use approach aligns with evidence suggesting that even minimal human support improves adherence and outcomes.

At a system level, future prospects depend on better integration and governance. Health systems may benefit from maintaining vetted app formularies, developing digital prescribing pathways, and aligning app use with existing care models. Training clinicians to evaluate digital tools and discuss them with patients will be increasingly important as apps become a routine part of mental health landscapes. Looking ahead, mental health apps are likely to evolve toward hybrid models that combine automation with human oversight, personalization, and data-driven feedback. Advances in adaptive interventions and integration with wearable data may improve relevance and engagement, but these developments must be accompanied by rigorous evaluation. The long-term role of apps will depend less on technological novelty and more on evidence quality, usability, and alignment with clinical and ethical standards.

Risks and limitations

Despite their potential, mental health apps carry substantial risks and limitations that constrain their practical impact. Engagement decay remains one of the most persistent challenges; many users discontinue use quickly, limiting exposure to therapeutic content and reducing effectiveness. Without sustained engagement strategies, real-world benefits are likely to remain modest.

Data privacy and security represent another major concern. Apps routinely collect sensitive psychological data, yet privacy policies are often opaque, and protections vary widely. Risks include unauthorized data sharing, secondary use for marketing or analytics, and inadequate safeguards against breaches. These issues undermine trust and raise ethical and legal questions, particularly when apps are recommended by clinicians or institutions.

There is also a risk of overreliance and delayed help-seeking. Users may interpret app use as sufficient treatment, even when symptoms worsen or risk increases. Because adverse effects are rarely monitored or reported in studies, the potential for harm remains poorly understood.

Finally, access, cost, and scalability present structural barriers. While many apps are free or low-cost initially, sustained access often requires subscriptions. Digital divides related to age, disability, language, and socioeconomic status further limit reach. Without deliberate policy and system-level planning, mental health apps may reinforce, rather than reduce, existing inequities in care.

Problematic Issues and Controversies

Criticisms and counterarguments

A central criticism of mental health apps concerns the discrepancy between marketing claims and demonstrated clinical benefit. App store descriptions and promotional materials frequently imply substantial improvements in mental health or even therapeutic equivalence to professional care. In contrast, empirical studies consistently show modest effect sizes and highly variable outcomes. Critics argue that this mismatch risks misleading users, clinicians, and policymakers, particularly when apps are positioned as solutions to systemic shortcomings in mental health services rather than as limited adjuncts. Another major point of contention involves the methodological quality of app research. Many studies are underpowered, rely on convenience samples, or use waitlist controls that inflate apparent effectiveness. Short follow-up periods make it difficult to assess durability of benefit, while selective outcome reporting contributes to publication bias. Independent replication is rare, and negative or null findings are less likely to appear in the literature. As a result, the evidence base may overstate effectiveness, especially for commercially successful apps.

Commercial incentives further complicate evaluation. A large proportion of mental health apps are developed by private companies whose business models depend on user acquisition and retention. This creates pressure to prioritize engagement metrics and appealing features over clinical rigor. Critics note that design choices aimed at maximizing usage, such as frequent notifications or gamification, may not align with therapeutic principles and, in some cases, could exacerbate anxiety or self-monitoring behaviors.

There is also debate over whether mental health apps inadvertently medicalize normal distress. By framing everyday stress, sadness, or emotional fluctuation as conditions requiring app-based intervention, critics argue that apps may lower thresholds for pathology and encourage self-diagnosis without professional input. Proponents counter that increased awareness and early self-monitoring can be beneficial. The controversy reflects broader tensions about the boundaries of mental health care in digital environments.

Some clinicians express concern that widespread reliance on apps could shift responsibility away from health systems and policymakers. Rather than expanding access to trained professionals, apps may be used as cost-containment tools, reinforcing a two-tier system in which marginalized populations receive primarily digital support while others access human care.

Ethical and social considerations

Ethical issues surrounding mental health apps are closely tied to user vulnerability and informed consent. Individuals seeking mental health support may be distressed, isolated, or uncertain about their needs, which can impair their ability to critically evaluate app claims. Privacy policies and terms of service are often lengthy, technical, and poorly understood, undermining meaningful consent. Ethical use therefore requires transparency not only about data practices but also about the app’s therapeutic scope and limitations.

Data governance is a particularly sensitive concern. Mental health apps routinely collect detailed information about mood, behavior, thoughts, and sometimes biometric data. These data may be shared with third parties for analytics or marketing, raising concerns about confidentiality and misuse. Even when anonymized, mental health data carry re-identification risks, with potential consequences for employment, insurance, or social stigma. Social equity considerations are equally important. While apps are often promoted as tools to expand access, digital divides related to age, disability, literacy, language, and socioeconomic status limit their reach. Apps designed primarily for Western, English-speaking users may inadequately serve culturally diverse populations. Moreover, subscription costs and device requirements can exclude those most in need of affordable care.

At a societal level, the normalization of app-based mental health support raises questions about the future of care relationships. If emotional support becomes increasingly mediated through commercial digital platforms, notions of responsibility, accountability, and human connection may shift. Addressing these ethical and social challenges requires coordinated efforts across research, regulation, and clinical practice to ensure that mental health apps serve as supportive tools rather than substitutes for comprehensive, equitable care.

Conclusion

Summary

This review has examined the effectiveness and limitations of mental health apps through the lens of current research, clinical practice, and ethical debate. The accumulated evidence indicates that mental health apps occupy a clearly defined but limited role within contemporary mental health care. When grounded in established therapeutic principles and used by motivated individuals with mild to moderate symptoms, apps can produce small to moderate improvements in psychological distress, particularly for depression, anxiety, stress, and emotional well-being. These benefits are most consistently observed in short-term outcomes and in low-risk populations.

At the same time, the review highlights substantial constraints. Effect sizes are generally modest, engagement is fragile, and real-world effectiveness often falls short of results reported in controlled trials. Evidence supporting app use in severe mental illness, high-risk situations, or complex comorbidity remains sparse. Importantly, mental health apps are not equivalent to clinician-delivered therapy and should not be positioned as replacements for professional assessment or treatment. Their greatest value lies in prevention, early intervention, self-management, and adjunctive support, particularly when integrated into stepped-care or clinician-guided models.

The review also underscores that the challenges associated with mental health apps are not purely technical. Issues of research quality, commercial incentives, data privacy, equity, and accountability shape both their perceived effectiveness and their real-world impact. Without careful governance and realistic expectations, apps risk being overpromoted as solutions to systemic problems in mental health care that require broader policy and workforce investment.

Future directions

Future progress in the field of mental health apps will depend on several critical developments. From a research perspective, there is a need for more rigorous, transparent, and independent studies, including longer follow-up periods, standardized outcome measures, and systematic reporting of adverse effects. Comparative effectiveness research that evaluates apps against existing low-intensity interventions, not only against inactive controls, will be particularly important.

Clinically, clearer frameworks are needed to guide appropriate selection, recommendation, and monitoring of apps. This includes the development of validated quality standards, curated app libraries, and clinician training in digital mental health literacy. Integration with health systems, electronic records, and referral pathways may enhance continuity of care and reduce the risk of fragmentation. At a societal level, future policy must address equity, privacy, and accountability. Ensuring that mental health apps complement rather than substitute for human care will be essential to avoid deepening disparities. Ultimately, the long-term role of apps will be determined not by their technological sophistication alone, but by the extent to which they are evidence-based, ethically governed, and aligned with patient-centered models of mental health care.

References

1. Technologies and Mobile Solutions in Psychiatric Treatment: Prospects for Telemedicine in Psychiatry
2. Current Approaches to the Diagnosis and Treatment of Anxiety and Depression
3. Andersson, G., Titov, N., Dear, B. F., Rozental, A., & Carlbring, P. (2019). Internet-delivered psychological treatments: From innovation to implementation. World Psychiatry, 18(1), 20–28. https://doi.org/10.1002/wps.20610
4. Baumel, A., Muench, F., Edan, S., & Kane, J. M. (2019). Objective user engagement with mental health apps: Systematic search and panel-based usage analysis. Journal of Medical Internet Research, 21(9), e14567. https://doi.org/10.2196/14567
5. Firth, J., Torous, J., Nicholas, J., et al. (2017). The efficacy of smartphone-based mental health interventions for depressive symptoms: A meta-analysis of randomized controlled trials. World Psychiatry, 16(3), 287–298. https://doi.org/10.1002/wps.20472
6. Firth, J., Torous, J., Nicholas, J., et al. (2018). Can smartphone mental health interventions reduce symptoms of anxiety? A meta-analysis of randomized controlled trials. Journal of Affective Disorders, 218, 15–22. https://doi.org/10.1016/j.jad.2017.04.046
7. Nicholas, J., Larsen, M. E., Proudfoot, J., & Christensen, H. (2015). Mobile apps for bipolar disorder: A systematic review of features and content quality. Journal of Medical Internet Research, 17(8), e198. https://doi.org/10.2196/jmir.4581